SC
CRSP icon

Saturna Capital’s CRISPR Therapeutics CRSP Stock Holding History

Saturna Capital’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,779
Closed -$459K – 159
2024
Q3 		$459K Hold
9,779
– – 0.01% 127
2024
Q2 		$528K Sell
9,779
-1,151
-11% -$66.6K 0.01% 124
2024
Q1 		$745K Hold
10,930
– – 0.01% 121
2023
Q4 		$684K Buy
+10,930
New +$604K 0.01% 121
2023
Q3 		– Sell
-3,733
Closed -$210K – 175
2023
Q2 		$210K Buy
+3,733
New +$212K ﹤0.01% 160
2021
Q4 		– Sell
-1,880
Closed -$210K – 175
2021
Q3 		$210K Buy
1,880
+100
+6% +$12.6K ﹤0.01% 168
2021
Q2 		$288K Buy
+1,780
New +$216K 0.01% 156
2021
Q1 		– Sell
-13,000
Closed -$1.99M – 167
2020
Q4 		$1.99M Sell
13,000
-1,200
-8% -$142K 0.05% 86
2020
Q3 		$1.19M Hold
14,200
– – 0.03% 94
2020
Q2 		$1.04M Buy
+14,200
New +$830K 0.03% 100
2020
Q1 		– Sell
-3,400
Closed -$207K – 180
2019
Q4 		$207K Buy
+3,400
New +$186K 0.01% 184

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return